SCHEMBL30384115

SCHEMBL30384115

O=C(/C=C/c1ccccc1)c1ccccc1OC[C@H](O)CN1CCCCC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 18/20 1.00
TSHR P16473 2/20 0.55
CYP2D6 P10635 1/20 0.55
HIF1A Q16665 1/20 0.55
USP2 O75604 1/20 0.53
ALDH1A1 P00352 1/20 0.53
LMNA P02545 1/20 0.53
TP53 P04637 1/20 0.53
GAA P10253 1/20 0.53
THRB P10828 1/20 0.53
ALOX15 P16050 1/20 0.53
HTT P42858 1/20 0.53
KMT2A Q03164 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25265259 1.00 ABCB1 (1.00) ABCB1TSHRCYP2D6HIF1AUSP2
SCHEMBL25192753 1.00 ABCB1 (1.00) ABCB1TSHRCYP2D6HIF1AUSP2
SCHEMBL30382699 0.84 ABCB1 (0.72) ABCB1LMNAKMT2A
SCHEMBL25201146 0.84 ABCB1 (0.72) ABCB1LMNAKMT2A
SCHEMBL25188674 0.81 ABCB1 (0.70) ABCB1TSHRCYP2D6HIF1AALDH1A1
SCHEMBL6548351 0.80 ABCB1 (0.67) ABCB1TSHRCYP2D6HIF1AKMT2A
SCHEMBL30382168 0.79 ABCB1 (0.69) ABCB1TSHRCYP2D6HIF1A
SCHEMBL25209899 0.79 ABCB1 (0.69) ABCB1TSHRCYP2D6HIF1A
SCHEMBL1330966 0.78 ABCB1 (1.00) ABCB1
SCHEMBL25210359 0.74 ABCG2 (0.63) ABCB1CYP2D6ALDH1A1LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4429763-A1 COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS Yewsavin, Inc. (US) 2024-09-18 EP disclosed
WO-2023086388-A1 COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS YewSavin, Inc. (US) 2023-05-19 WO disclosed